An open-label Phase II trial to investigate the efficacy

  • Dudek, Arkadiusz Z (PI)

Project: Research project

Project Details

Description

An open-label Phase II trial to investigate the efficacy, safety, and pharmacokinetics of a single dose of 200 mg i.v. BI 2536 BS administered every 21 days in patients w
StatusFinished
Effective start/end date8/15/078/15/08

Funding

  • Boehringer-Ingelheim Pharmaceuticals

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.